BNGO

Bionano Genomics, Inc.

NasdaqAdd to watchlist

Healthcare · Medical Instruments & Supplies

$1.73

−$0.01−0.57%

Delayed · 2026-09-18T20:00:00.000Z · marketstack

Aug 24, 2026$1.73

+$0.51+41.80%over 1M

Session

Day range22% of range

$1.69$1.87

Fundamentals

Visualize fundamentals and more

Market cap: 19.97M
P/E ratio: -

Revenue grew −7.37% in FY2025, +16.24% slower than its sector. The median across Healthcare companies this platform tracks is +8.87%.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2025.

Reimbursement
Data privacy
FDA approval
Litigation
Going concern
Cybersecurity
Russia and Ukraine
Debt covenants

And 15 more.

Reimbursement
Depending on the billing arrangement and applicable law, we bill various payors, including Medicare, Medicaid, private insurance companies, private healthcare institutions, and patients, all of which have different billing requirements. We generally bill …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

Sep 14 Regulation FD disclosure Company filing 8-K
Sep 4 Luderer Albert bought 4,000 shares Insider trading Form 4 Interim Chief Executive, about $5k
Aug 21 Luderer Albert bought 4,000 shares Insider trading Form 4 Interim Chief Executive, about $5k

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 18, 2026 · the last close

Bionano Genomics, Inc. investor relations

What BNGO has filed with the SEC. This is not Bionano Genomics, Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Bionano Genomics, Inc.

Also filed under Medical Instruments & Supplies, ranked by how closely they sit beside BNGO.

ISRGIntuitive Surgical Inc.compare with BNGO
BDXBecton Dickinson & Co.compare with BNGO
COO

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2025.

Reimbursement
Data privacy
FDA approval
Litigation
Going concern
Cybersecurity
Russia and Ukraine
Debt covenants

And 15 more.

Reimbursement
Depending on the billing arrangement and applicable law, we bill various payors, including Medicare, Medicaid, private insurance companies, private healthcare institutions, and patients, all of which have different billing requirements. We generally bill …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

What an account lets you do with Bionano Genomics, Inc.

Be told the moment a BNGO insider trades
Put Bionano Genomics, Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Bionano Genomics, Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Bionano Genomics, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

Session

Fundamentals

What it says it is exposed to

Recent activity

Discussion

Bionano Genomics, Inc. investor relations

Companies like Bionano Genomics, Inc.

What it says it is exposed to

Ask about Bionano Genomics, Inc.

What an account lets you do with Bionano Genomics, Inc.

Recent activity